|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–-E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vermeulen E, Zamora-Ros R, Duell EJ,
Luján-Barroso L, Boeing H, Aleksandrova K, Bueno-de-Mesquita HB,
Scalbert A, Romieu I, Fedirko V, et al: Dietary flavonoid intake
and esophageal cancer risk in the European prospective
investigation into cancer and nutrition cohort. Am J Epidemiol.
178:570–581. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pennathur A, Farkas A, Krasinskas AM,
Ferson PF, Gooding WE, Gibson MK, Schuchert MJ, Landreneau RJ and
Luketich JD: Esophagectomy for T1 esophageal cancer: Outcomes in
100 patients and implications for endoscopic therapy. Ann Thorac
Surg. 87:1048–1055. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hayashi Y, Correa AM, Hofstetter WL,
Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS,
Welsh J, et al: Patients with high body mass index tend to have
lower stage of esophageal carcinoma at diagnosis. Dis Esophagus.
25:614–622. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng J, Xu C, Chu D, Zhang X, Li J, Ji G,
Hong L, Feng Q, Li X, Wu G, et al: Human leukocyte antigen G is
associated with esophageal squamous cell carcinoma progression and
poor prognosis. Immunol Lett. 161:13–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harris KS, Durek T, Kaas Q, Poth AG,
Gilding EK, Conlan BF, Saska I, Daly NL, van der Weerden NL, Craik
DJ and Anderson MA: Efficient backbone cyclization of linear
peptides by a recombinant asparaginyl endopeptidase. Nat Commun.
6:101992015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao L, Hua T, Crowley C, Ru H, Ni X, Shaw
N, Jiao L, Ding W, Qu L, Hung LW, et al: Structural analysis of
asparaginyl endopeptidase reveals the activation mechanism and a
reversible intermediate maturation stage. Cell Res. 24:344–358.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miller G, Matthews SP, Reinheckel T,
Fleming S and Watts C: Asparagine endopeptidase is required for
normal kidney physiology and homeostasis. FASEB J. 25:1606–1617.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Descamps D, Le Gars M, Balloy V, Barbier
D, Maschalidi S, Tohme M, Chignard M, Ramphal R, Manoury B and
Sallenave JM: Toll-like receptor 5 (TLR5), IL-1β secretion, and
asparagine endopeptidase are critical factors for alveolar
macrophage phagocytosis and bacterial killing. Proc Natl Acad Sci
USA. 109:pp. 1619–1624. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sepulveda FE, Maschalidi S, Colisson R,
Heslop L, Ghirelli C, Sakka E, Lennon-Duménil AM, Amigorena S,
Cabanie L and Manoury B: Critical role for asparagine endopeptidase
in endocytic Toll-like receptor signaling in dendritic cells.
Immunity. 31:737–748. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morita Y, Araki H, Sugimoto T, Takeuchi K,
Yamane T, Maeda T, Yamamoto Y, Nishi K, Asano M, Shirahama-Noda K,
et al: Legumain/asparaginyl endopeptidase controls extracellular
matrix remodeling through the degradation of fibronectin in mouse
renal proximal tubular cells. FEBS Lett. 581:1417–1424. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Choi SJ, Reddy SV, Devlin RD, Menaa C,
Chung H, Boyce BF and Roodman GD: Identification of human
asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast
formation and bone resorption. J Biol Chem. 274:27747–27753. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xing W, Baylink D, Kesavan C, Hu Y, Kapoor
S, Chadwick RB and Mohan S: Global gene expression analysis in the
bones reveals involvement of several novel genes and pathways in
mediating an anabolic response of mechanical loading in mice. J
Cell Biochem. 96:1049–1060. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dickinson D: Cysteine peptidases of
mammals: Their biological roles and potential effects in the oral
cavity and other tissues in health and disease. Crit Rev Oral Biol
Med. 13:238–275. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gawenda J, Traub F, Lück HJ, Kreipe H and
von Wasielewski R: Legumain expression as a prognostic factor in
breast cancer patients. Breast Cancer Res Treat. 102:1–6. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brix K, McInnes J, Al-Hashimi A, Rehders
M, Tamhane T and Haugen MH: Proteolysis mediated by cysteine
cathepsins and legumain-recent advances and cell biological
challenges. Protoplasma. 252:755–774. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Holland M, Castro FV, Alexander S, Smith
D, Liu J, Walker M, Bitton D, Mulryan K, Ashton G, Blaylock M, et
al: RAC2, AEP, and ICAM1 expression are associated with CNS disease
in a mouse model of pre-B childhood acute lymphoblastic leukemia.
Blood. 118:638–649. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen JM, Dando PM, Rawlings ND, Brown MA,
Young NE, Stevens RA, Hewitt E, Watts C and Barrett AJ: Cloning,
isolation, and characterization of mammalian legumain, an
asparaginyl endopeptidase. J Biol Chem. 272:8090–8098. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu C, Sun C, Huang H, Janda K and
Edgington T: Overexpression of legumain in tumors is significant
for invasion/metastasis and a candidate enzymatic target for
prodrug therapy. Cancer Res. 63:2957–2964. 2003.PubMed/NCBI
|
|
21
|
Murthy RV, Arbman G, Gao J, Roodman GD and
Sun XF: Legumain expression in relation to clinicopathologic and
biological variables in colorectal cancer. Clin Cancer Res.
11:2293–2299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ohno Y, Nakashima J, Izumi M, Ohori M,
Hashimoto T and Tachibana M: Association of legumain expression
pattern with prostate cancer invasiveness and aggressiveness. World
J Urol. 31:359–364. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu JK, Forman S, Moorthy CR and Benzil
DL: Update on treatment modalities for optic nerve sheath
meningiomas. Neurosurg Focus. 14:e72003. View Article : Google Scholar
|
|
24
|
Napier KJ, Scheerer M and Misra S:
Esophageal cancer: A Review of epidemiology, pathogenesis, staging
workup and treatment modalities. World J Gastrointest Oncol.
6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Wang Z, Zhang G, Zhu Q, Zeng H,
Wang T, Gao F, Qi Z, Zhang J and Wang R: High TRAF6 expression is
associated with esophageal carcinoma recurrence and prompts cancer
cell invasion. Oncol Res. 25:485–493. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin Y, Qiu Y, Xu C, Liu Q, Peng B,
Kaufmann GF, Chen X, Lan B, Wei C, Lu D, et al: Functional role of
asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion
and metastasis. J Natl Cancer Inst. 106:dju0122014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Murray GI, Duncan ME, O'Neil P, McKay JA,
Melvin WT and Fothergill JE: Matrix metalloproteinase-1 is
associated with poor prognosis in oesophageal cancer. J Pathol.
185:256–261. 1998. View Article : Google Scholar : PubMed/NCBI
|
